Survival factors in rhino-orbital-cerebral mucormycosis (Q40640053)

22 September 2017

1 reference

title

Survival factors in rhino-orbital-cerebral mucormycosis (English)

1 reference

22 September 2017

Yohai RA

1

1 reference

22 September 2017

Bullock JD

series ordinal

2

1 reference

22 September 2017

Aziz AA

series ordinal

3

1 reference

22 September 2017

Markert RJ

series ordinal

4

1 reference

22 September 2017

1 July 1994

1 reference

22 September 2017

Survey of Ophthalmology

1 reference

22 September 2017

39

1 reference

22 September 2017

1

1 reference

22 September 2017

3-22

1 reference

Effects of iron and desferrioxamine on Rhizopus infection.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Twenty-five years' experience treating cerebro-rhino-orbital mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Report of two cases and a review of clinical and experimental experience with amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Orbitofacial mucormycosis with unusual pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis; a new disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

1 reference

7 January 2021

Rhinocerebral phycomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Hairy cell leukemia and mucormycosis. Treatment with alpha-2 interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

VII Rhinocerebral and Otologic Mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Patient survival factors in paranasal sinus mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis infection in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Orbital apex syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis. Discussion and report of a case involving the maxillary sinus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Cunninghamella: a newly recognized cause of rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinomaxillary mucormycosis in a kidney transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Cerebral mucormycosis in two cases of acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis of the nose and paranasal sinuses

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Zygomycosis of the maxillary sinus and palate caused by Basidiobolus haptosporus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Venous thrombosis: clinical and experimental MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

1 reference

7 January 2021

Rhinocerebral mucormycosis: use of liposomal amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis. Presentation of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis: management and survival after carotid occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Craniofacial mucormycosis: assessment with CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Acute orbital mucormycosis. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Ocular manifestations of acute mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Asperillosis of the orbit. Report of ten cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis in a Transplant Recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Orofacial mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Benign Mucor Colonization (Fungus Ball) Associated With Chronic Sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Acute proptosis and blindness in a patient with orbital phycomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Bilateral Cavernous Sinus Thrombosis due to Mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Cure of Mucormycosis in a Renal Transplant Patient Receiving Ciclosporin with Maintenance of Immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Management of limited rhino-orbital mucormycosis without exenteration

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

1 reference

7 January 2021

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Cephalic phycomycosis: a report of eight cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Subacute zygomycosis of the orbit

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral Mucormycosis and Juvenile Diabetes Mellitus: Report of a Case with Recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis: a case report with magnetic resonance imaging findings

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis: premortem diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Cerebral mucormycosis: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Cure of zygomycosis caused by a lipase-producing Rhizopus rhizopodiformis strain in a renal transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis: results of aggressive surgical debridement and amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Orbital mucormycosis with survival

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Nosocomial infection by Rhizomucor pusillus in a clinical haematology unit

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Paranasal sinus mucormycosis in an immunologically competent host

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Orbital mucormycosis with retinal and ciliary artery occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral phycomycosis; combined approach therapy: case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis. Report of 11 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Cerebral mucormycosis--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Cunninghamella bertholletiae infection associated with deferoxamine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis in leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mechanism of action and biochemical selectivity of allylamine antimycotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Ocular and orbital phycomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Chronic sinusitis caused by zygomycosis and aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Fatal mucormycosis therapy associated with deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Survival in cerebro-rhino-orbital zygomycosis and cavernous sinus thrombosis with combined therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis with extension to the posterior fossa: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Ocular invasion in mucormycosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Acute Rhino-Orbito-Cerebral Mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

A rapidly fatal palatal ulcer: rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis in deferoxamine-treated patients on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Mucormycosis after open fracture injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Acute, life-threatening disease first appearing as odontogenic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Disseminated zygomycosis masquerading as cerebral lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

MR findings in rhinocerebral mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Two cases of orbital phycomycosis with recovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis: computed tomographic imaging of cavernous sinus thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Rhinocerebral mucormycosis in renal transplant recipients: report of three cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

Survival from sino-orbital mucormycosis due to Rhizopus rhizopodiformis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

In-vitro studies with SF 86-327, a new orally active allylamine derivative.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2805%2980041-4

7 January 2021

10.1016/S0039-6257(05)80041-4

Identifiers

DOI

1 reference

22 September 2017

1 reference